EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

40 hedge funds and large institutions have $128M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.1M
2
+$7.63M
3
+$2.4M
4
Axa
Axa
France
+$774K
5
RPAM
Rhenman & Partners Asset Management
Sweden
+$737K

Top Sellers

1
-$6.55M
2
-$2.44M
3
-$1.15M
4
BIT
BlackRock Institutional Trust
California
-$905K
5
VAM
Visium Asset Management
New York
-$570K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$244K
27
$234K
28
$234K
29
$219K
30
$219K
31
$216K
32
$195K
33
$180K
34
$148K
35
$121K
36
$85K
37
$38K
38
$16K
39
$16K
40
$8K
41
$3K
42
$2K
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2